Teligent Inc. (TLGT) announced after the close Wednesday that it has received FDA approval for its Diflorasone Diacetate Ointment 0.05%.
Teligent has gapped open sharply higher Thursday morning and is now up 0.46 at $3.73 on above average volume. The stock has risen to a 5-month high.
For comments and feedback contact: editorial@rttnews.com
Business News